Shl Telemedicine Financials

SHMLF

Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2024 Currency USD FYE December

This page shows Shl Telemedicine (SHMLF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SHMLF FY2024 2026-04-22

SHMLF’s recent story is balance-sheet contraction, where asset shrinkage mattered more than operating cash burn.

From FY2021 to FY2024, total assets fell from $129.6M to $80.8M and goodwill nearly halved from $37.5M to $19.1M, yet FY2024 operating cash flow was only -$372K against a net loss of -$27.8M. That mismatch points to non-cash balance-sheet resets carrying much of the loss, rather than the business burning cash on the same scale.

The company looks lightly levered rather than debt-dependent: long-term debt fell to $3.6M and debt-to-equity to 0.1x by FY2024. But liquidity tightened at the same time, with the current ratio slipping from 2.3x in FY2023 to 1.0x, so near-term flexibility now depends more on working capital discipline than on new borrowing.

Capex stayed below depreciation in each of the last four years, including $950K versus $7.5M in FY2024, while revenue held near $57M after FY2022. That combination suggests maintenance or downsizing of the asset base, not visible expansion, which helps keep free cash burn relatively contained even as reported earnings weakened.

Financial Health Signals

Financial health score pending refresh

We are recalculating Shl Telemedicine's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

3/8

Shl Telemedicine passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.01x

For every $1 of reported earnings, Shl Telemedicine generates $0.01 in operating cash flow (-$372K OCF vs -$27.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$56.8M

YoY-0.5%

Shl Telemedicine generated $56.8M in revenue in fiscal year 2024. This represents a decrease of 0.5% from the prior year.

EBITDA

N/A

Net Income

-$27.8M

YoY-304.9%

Shl Telemedicine reported -$27.8M in net income in fiscal year 2024. This represents a decrease of 304.9% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

-$1.3M

YoY+52.5%

Shl Telemedicine generated -$1.3M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 52.5% from the prior year.

Cash & Debt

$7.7M

YoY+14.7%

Shl Telemedicine held $7.7M in cash against $3.6M in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

16M

YoY+0.0%

Shl Telemedicine had 16M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

-48.9%

YoY-36.9pp

Shl Telemedicine's net profit margin was -48.9% in fiscal year 2024, showing the share of revenue converted to profit. This is down 36.9 percentage points from the prior year.

Return on Equity

-70.7%

YoY-61.7pp

Shl Telemedicine's ROE was -70.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 61.7 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$950K

YoY-26.3%

Shl Telemedicine invested $950K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 26.3% from the prior year.

SHMLF Income Statement

Metric	FY24	FY23	FY22	FY21	FY20
Revenue	$56.8M-0.5%	$57.1M-3.3%	$59.0M+19.0%	$49.6M+23.4%	$40.2M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A
Interest Expense	$319K-7.0%	$343K-5.0%	$361K-4.5%	$378K+218.5%	-$319K
Income Tax	$939K+5.4%	$891K-18.8%	$1.1M+141.1%	$455K+326.4%	-$201K
Net Income	-$27.8M-304.9%	-$6.9M-3288.4%	$215K+101.5%	-$13.9M-5108.6%	$278K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q2'22	Q4'21
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SHMLF Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20
Total Assets	$80.8M-28.6%	$113.0M+2.0%	$110.8M-14.5%	$129.6M	N/A
Current Assets	$27.5M-31.4%	$40.1M+24.1%	$32.3M-29.6%	$45.9M	N/A
Cash & Equivalents	$7.7M+14.7%	$6.7M+49.3%	$4.5M-69.8%	$14.8M+258.4%	$4.1M
Inventory	$1.2M-66.1%	$3.5M-10.8%	$3.9M-7.7%	$4.2M	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A
Goodwill	$19.1M-42.0%	$33.0M-2.3%	$33.7M-10.0%	$37.5M	N/A
Total Liabilities	$41.5M+13.5%	$36.6M-28.9%	$51.5M-25.2%	$68.8M	N/A
Current Liabilities	$26.5M+52.2%	$17.4M-2.2%	$17.8M+2.7%	$17.4M	N/A
Long-Term Debt	$3.6M-25.4%	$4.8M-48.4%	$9.3M-16.9%	$11.2M	N/A
Total Equity	$39.2M-48.7%	$76.5M+29.0%	$59.3M-2.4%	$60.8M+60.4%	$37.9M
Retained Earnings	-$108.2M-35.1%	-$80.1M-9.7%	-$73.1M-0.1%	-$73.0M	N/A

Metric	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q2'22	Q4'21
Total Assets	$80.8M-21.5%	$102.8M-9.0%	$113.0M-5.7%	$119.8M+8.2%	$110.8M-3.1%	$114.3M-11.8%	$129.6M
Current Assets	$27.5M-17.0%	$33.1M-17.3%	$40.1M-9.8%	$44.4M+37.5%	$32.3M-16.3%	$38.6M-15.8%	$45.9M
Cash & Equivalents	$7.7M-29.5%	$10.9M+62.7%	$6.7M-35.9%	$10.4M+132.8%	$4.5M-72.7%	$16.4M+10.6%	$14.8M
Inventory	$1.2M-59.6%	$2.9M-16.1%	$3.5M-13.4%	$4.0M+3.0%	$3.9M-21.7%	$5.0M+17.9%	$4.2M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$19.1M-39.9%	$31.8M-3.5%	$33.0M+2.0%	$32.3M-4.2%	$33.7M+0.9%	$33.4M-10.9%	$37.5M
Total Liabilities	$41.5M+27.4%	$32.6M-11.0%	$36.6M-9.0%	$40.2M-21.9%	$51.5M-12.2%	$58.6M-14.8%	$68.8M
Current Liabilities	$26.5M+74.2%	$15.2M-12.6%	$17.4M+9.8%	$15.9M-10.9%	$17.8M+10.2%	$16.2M-6.9%	$17.4M
Long-Term Debt	$3.6M-22.6%	$4.6M-3.6%	$4.8M-45.7%	$8.8M-4.9%	$9.3M-0.2%	$9.3M-16.7%	$11.2M
Total Equity	$39.2M-44.1%	$70.3M-8.1%	$76.5M-4.0%	$79.6M+34.3%	$59.3M+6.5%	$55.7M-8.4%	$60.8M
Retained Earnings	-$108.2M-28.6%	-$84.1M-5.0%	-$80.1M-6.4%	-$75.3M-3.0%	-$73.1M-0.1%	-$73.0M0.0%	-$73.0M

SHMLF Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$372K+75.1%	-$1.5M-1949.3%	-$73K-139.5%	$185K-96.0%	$4.7M
Capital Expenditures	$950K-26.3%	$1.3M-22.4%	$1.7M+165.8%	$625K-27.2%	$859K
Free Cash Flow	-$1.3M+52.5%	-$2.8M-60.6%	-$1.7M-294.1%	-$440K-111.5%	$3.8M
Investing Cash Flow	$6.0M+164.6%	-$9.3M-45.3%	-$6.4M+84.3%	-$41.0M-435.8%	-$7.6M
Financing Cash Flow	-$4.9M-135.6%	$13.7M+699.2%	-$2.3M-104.5%	$51.1M+6964.7%	$723K
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q2'22	Q4'21
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SHMLF Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A
Net Margin	-48.9%-36.9pp	-12.0%-12.4pp	0.4%+28.4pp	-28.1%-28.8pp	0.7%
Return on Equity	-70.7%-61.7pp	-9.0%-9.3pp	0.4%+23.3pp	-22.9%-23.6pp	0.7%
Return on Assets	-34.4%-28.3pp	-6.1%-6.3pp	0.2%+10.9pp	-10.7%	N/A
Current Ratio	1.04-1.3	2.30+0.5	1.81-0.8	2.64	N/A
Debt-to-Equity	0.09+0.0	0.06-0.1	0.16-0.0	0.18	N/A
FCF Margin	-2.3%+2.6pp	-4.9%-1.9pp	-2.9%-2.0pp	-0.9%-10.4pp	9.5%

Metric	Q4'24	Q2'24	Q4'23	Q2'23	Q4'22	Q2'22	Q4'21
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.04-1.1	2.17-0.1	2.30-0.5	2.80+1.0	1.81-0.6	2.39-0.3	2.64
Debt-to-Equity	0.09+0.0	0.070.0	0.06-0.0	0.11-0.0	0.16-0.0	0.17-0.0	0.18
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is Shl Telemedicine's annual revenue?

Shl Telemedicine (SHMLF) reported $56.8M in total revenue for fiscal year 2024. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Shl Telemedicine's revenue growing?

Shl Telemedicine (SHMLF) revenue declined by 0.5% year-over-year, from $57.1M to $56.8M in fiscal year 2024.

Is Shl Telemedicine profitable?

No, Shl Telemedicine (SHMLF) reported a net income of -$27.8M in fiscal year 2024, with a net profit margin of -48.9%.

How much debt does Shl Telemedicine have?

As of fiscal year 2024, Shl Telemedicine (SHMLF) had $7.7M in cash and equivalents against $3.6M in long-term debt.

What is Shl Telemedicine's net profit margin?

Shl Telemedicine (SHMLF) had a net profit margin of -48.9% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Shl Telemedicine's return on equity (ROE)?

Shl Telemedicine (SHMLF) has a return on equity of -70.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Shl Telemedicine's free cash flow?

Shl Telemedicine (SHMLF) generated -$1.3M in free cash flow during fiscal year 2024. This represents a 52.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Shl Telemedicine's operating cash flow?

Shl Telemedicine (SHMLF) generated -$372K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Shl Telemedicine's total assets?

Shl Telemedicine (SHMLF) had $80.8M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Shl Telemedicine's capital expenditures?

Shl Telemedicine (SHMLF) invested $950K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Shl Telemedicine have outstanding?

Shl Telemedicine (SHMLF) had 16M shares outstanding as of fiscal year 2024.

What is Shl Telemedicine's current ratio?

Shl Telemedicine (SHMLF) had a current ratio of 1.04 as of fiscal year 2024, which is considered adequate.

What is Shl Telemedicine's debt-to-equity ratio?

Shl Telemedicine (SHMLF) had a debt-to-equity ratio of 0.09 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Shl Telemedicine's return on assets (ROA)?

Shl Telemedicine (SHMLF) had a return on assets of -34.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Shl Telemedicine's cash runway?

Based on fiscal year 2024 data, Shl Telemedicine (SHMLF) had $7.7M in cash against an annual operating cash burn of $372K. This gives an estimated cash runway of approximately 248 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Shl Telemedicine's Piotroski F-Score?

Shl Telemedicine (SHMLF) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Shl Telemedicine's earnings high quality?

Shl Telemedicine (SHMLF) has an earnings quality ratio of 0.01x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.